English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Open

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

A series of cinnamido-propionone conjugates (4–6a-h and 7a-f) has been designed, synthesized and evaluated for their anticancer potential against some human cancer cell lines. Among them, conjugates 6d and 6g have shown significant cytotoxic activity against prostate cancer cells (DU-145) displaying IC50 of 7.48 and 8.91μM respectively. Studies to understand the mechanism of action of 6d and 6g indicate that they inhibit the tubulin polymerization thereby arresting the cell cycle in G2/M phase. Furthermore, studies such as mitochondrial membrane potential and Annexin V-FITC assay suggested that these conjugates 6d and 6g induced cell death by apoptosis. The molecular docking studies suggested that the binding by these conjugates takes place at the colchicine site of the tubulin protein

Arylcinnamido-propionone conjugates as tubulin polymerization inhibitors and apoptotic inducers